Tuder RM - Search Results

1

Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension.

Lee MH, Sanders L, Kumar R, Hernandez-Saavedra D, Yun X, Ford JA, Perez MJ, Mickael C, Gandjeva A, Koyanagi DE, Harral JW, Irwin DC, Kassa B, Eckel RH, Shimoda LA, Graham BB, Tuder RM. Lee MH, et al. Among authors: tuder rm. Am J Physiol Lung Cell Mol Physiol. 2022 Sep 1;323(3):L355-L371. doi: 10.1152/ajplung.00039.2022. Epub 2022 Jun 28. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35763400 Free PMC article.

2

Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.

Voelkel NF, Tuder RM, Bridges J, Arend WP. Voelkel NF, et al. Among authors: tuder rm. Am J Respir Cell Mol Biol. 1994 Dec;11(6):664-75. doi: 10.1165/ajrcmb.11.6.7946395. Am J Respir Cell Mol Biol. 1994. PMID: 7946395

3

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

Voelkel NF, Tuder RM, Wade K, Höper M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F. Voelkel NF, et al. Among authors: tuder rm. J Clin Invest. 1996 Jun 1;97(11):2491-8. doi: 10.1172/JCI118696. J Clin Invest. 1996. PMID: 8647941 Free PMC article.

4

Histopathology of pulmonary hypertension.

Tuder RM, Lee SD, Cool CC. Tuder RM, et al. Chest. 1998 Jul;114(1 Suppl):1S-6S. doi: 10.1378/chest.114.1_supplement.1s-a. Chest. 1998. PMID: 9676599 No abstract available.

5

Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Jakkula M, et al. Among authors: tuder rm. Am J Physiol Lung Cell Mol Physiol. 2000 Sep;279(3):L600-7. doi: 10.1152/ajplung.2000.279.3.L600. Am J Physiol Lung Cell Mol Physiol. 2000. PMID: 10956636 Free article.

6

Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.

Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM, Voelkel NF. Tuder RM, et al. J Pathol. 2001 Oct;195(3):367-74. doi: 10.1002/path.953. J Pathol. 2001. PMID: 11673836

7

Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.

Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Le Cras TD, et al. Among authors: tuder rm. Am J Physiol Lung Cell Mol Physiol. 2002 Sep;283(3):L555-62. doi: 10.1152/ajplung.00408.2001. Am J Physiol Lung Cell Mol Physiol. 2002. PMID: 12169575 Free article.

8

Attenuation of chronic hypoxic pulmonary hypertension by simvastatin.

Girgis RE, Li D, Zhan X, Garcia JG, Tuder RM, Hassoun PM, Johns RA. Girgis RE, et al. Among authors: tuder rm. Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H938-45. doi: 10.1152/ajpheart.01097.2002. Epub 2003 May 15. Am J Physiol Heart Circ Physiol. 2003. PMID: 12750068 Free article.

9

Expression of human herpesvirus 8 in primary pulmonary hypertension.

Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, Voelkel NF. Cool CD, et al. Among authors: tuder rm. N Engl J Med. 2003 Sep 18;349(12):1113-22. doi: 10.1056/NEJMoa035115. N Engl J Med. 2003. PMID: 13679525 Free article.

10

Oxidative stress in severe pulmonary hypertension.

Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF. Bowers R, et al. Among authors: tuder rm. Am J Respir Crit Care Med. 2004 Mar 15;169(6):764-9. doi: 10.1164/rccm.200301-147OC. Epub 2003 Dec 30. Am J Respir Crit Care Med. 2004. PMID: 14701708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters